Repository for Antibody Incompatible Transplantation Evidence

Recommendations for living donor kidney transplantation

Nefrologia (Engl Ed). 2022 Dec;42 Suppl 2:5-132 doi: 10.1016/j.nefroe.2022.07.001.
Abstract

This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this Guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes. Moreover, the role of living donors in the current KT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDKT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations. This Guide does not forget that LDKT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDKT programmes when evaluating potential donors. Finally, this Guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees.

Categorisation
LEVEL OF EVIDENCE: Clinical Practice Recommendations
LANGUAGE: English
ORGAN TYPE: Kidney
Metadata
KEYWORDS: ABO incompatible; Altruistic donor; Crossmatch; Desensitization; Donor lifestyle; Donor profile; Donor protection; Donor risks; End stage renal disease; Ethical; Guidelines; HLA incompatible; HLA typing; Immunosuppression; Incompatibility; Legal; Living donor nephrectomy; Living kidney donor; Living kidney transplant; Paediatric transplant; Paired renal transplant; Rejection; Renal transplantation; Retransplants; Surgical; Surgical complications; Survival
MESH HEADINGS: Humans; Kidney Transplantation; Kidney; Living Donors; Kidney Failure, Chronic; Renal Insufficiency, Chronic